However, in approximately 60% of cases, antineuronal antibodies are present, such as the anti-Hu antibody in small cell lung cancer, anti-Ta antibody in testicular cancers, anti-NMDA NR1 in ovarian teratomas, or anti-NMDA NR2 in SLE patients [25]. This evidence concerns the gene TOR1A and testicular cancer.